Display options
Cite
Khasawneh FA, Karim A, Mahmood T, et al. Safety and feasibility of antibiotic de-escalation in bacteremic pneumonia. Infect Drug Resist. 2014;7:177-82doi: 10.2147/IDR.S65928.
Khasawneh, F. A., Karim, A., Mahmood, T., Ahmed, S., Jaffri, S. F., & Mehmood, M. (2014). Safety and feasibility of antibiotic de-escalation in bacteremic pneumonia. Infection and drug resistance, 7177-82. https://doi.org/10.2147/IDR.S65928
Khasawneh, Faisal A, et al. "Safety and feasibility of antibiotic de-escalation in bacteremic pneumonia." Infection and drug resistance vol. 7 (2014): 177-82. doi: https://doi.org/10.2147/IDR.S65928
Khasawneh FA, Karim A, Mahmood T, Ahmed S, Jaffri SF, Mehmood M. Safety and feasibility of antibiotic de-escalation in bacteremic pneumonia. Infect Drug Resist. 2014 Jun 27;7:177-82. doi: 10.2147/IDR.S65928. eCollection 2014. PMID: 25061323; PMCID: PMC4085320.
Copy Download .nbib Format: NLM
Share it on

Infect Drug Resist. 2014 Jun 27;7:177-82. doi: 10.2147/IDR.S65928. eCollection 2014.

Safety and feasibility of antibiotic de-escalation in bacteremic pneumonia.

Infection and drug resistance

Faisal A Khasawneh, Adnanul Karim, Tashfeen Mahmood, Subhan Ahmed, Sayyed F Jaffri, Mansoor Mehmood

Affiliations

  1. Section of Infectious Diseases, Texas Tech University Health Sciences Center, Amarillo, TX, USA.
  2. Department of Internal Medicine, Texas Tech University Health Sciences Center, Amarillo, TX, USA.
  3. Department of Internal Medicine, Deaconess Hospital, Evansville, IN, USA.
  4. Section of Nephrology, Department of Internal Medicine, University of Oklahoma, Tulsa, OK, USA.

PMID: 25061323 PMCID: PMC4085320 DOI: 10.2147/IDR.S65928

Abstract

BACKGROUND: Antibiotic de-escalation is a potential strategy advocated to conserve the effectiveness of broad-spectrum antibiotics. The aim of this study was to examine the safety and feasibility of antibiotic de-escalation in patients admitted with bacteremic pneumonia.

METHODS: A retrospective chart review was done for patients with bacteremic pneumonia admitted to Northwest Texas Hospital in Amarillo, TX, USA, during 2008. Antibiotic de-escalation was defined as changing the empiric antibiotic regimen to a culture-directed single agent with a narrower spectrum than the original regimen.

RESULTS: Sixty-eight patients were admitted with bacteremic pneumonia. Eight patients were not eligible for de-escalation. Among the 60 patients who were eligible for de-escalation, the treating physicians failed to de-escalate antibiotics in 27 cases (45.0%). Discharge to a long-term care facility predicted failure to de-escalate antibiotics, while an infectious diseases consultation was significantly associated with antibiotic de-escalation. The average daily cost of antibacterial therapy in the de-escalation group was $25.7 compared with $61.6 in the group where de-escalation was not implemented. The difference in mean length of hospital stay and mortality between the two groups was not statistically significant.

CONCLUSION: Antibiotic de-escalation is a safe management strategy but unfortunately is not widely adopted. Although bacterial resistance poses a significant threat and is rising, antimicrobial de-escalation has emerged as a potential intervention that can conserve the effectiveness of broad-spectrum antibiotics without compromising the patient's outcome. This practice is becoming important in the face of slow development of new anti-infective agents.

Keywords: antibiotic de-escalation strategy; bacteremia; lung infection

References

  1. Curr Opin Crit Care. 2006 Oct;12(5):452-7 - PubMed
  2. Chest. 2008 Mar;133(3):618-24 - PubMed
  3. Crit Care Med. 2007 Aug;35(8):1888-95 - PubMed
  4. Antimicrob Agents Chemother. 2003 Sep;47(9):2756-64 - PubMed
  5. Am J Respir Crit Care Med. 2004 Feb 1;169(3):342-7 - PubMed
  6. Arch Gerontol Geriatr. 2012 Mar-Apr;54(2):e19-22 - PubMed
  7. Am J Med. 2001 Apr 15;110(6):451-7 - PubMed
  8. BMJ. 2004 Mar 20;328(7441):668 - PubMed
  9. Intensive Care Med. 2013 Feb;39(2):165-228 - PubMed
  10. Am J Med. 2010 Jul;123(7):631-7 - PubMed
  11. Crit Care. 2012 Feb 15;16(1):R28 - PubMed
  12. Chest. 2007 Feb;131(2):466-73 - PubMed
  13. Can J Infect Dis. 2004 Jan;15(1):21-4 - PubMed
  14. Infection. 2013 Feb;41(1):211-4 - PubMed
  15. Infection. 2011 Aug;39(4):319-25 - PubMed
  16. J Trauma. 2009 May;66(5):1343-8 - PubMed
  17. Semin Respir Crit Care Med. 2006 Feb;27(1):45-50 - PubMed
  18. Clin Infect Dis. 2006 Jan 15;42 Suppl 2:S72-81 - PubMed
  19. N Engl J Med. 2014 Feb 6;370(6):543-51 - PubMed
  20. Clin Infect Dis. 2013 Nov;57(9):1246-52 - PubMed
  21. Clin Infect Dis. 2005 Jul 15;41(2):149-58 - PubMed
  22. Emerg Med J. 2003 Nov;20(6):521-3 - PubMed
  23. J Hosp Infect. 2010 Mar;74(3):304-5 - PubMed
  24. Clin Chest Med. 2011 Sep;32(3):517-34 - PubMed
  25. J Infect. 2009 Oct;59(4):232-9 - PubMed
  26. Infection. 2010 Oct;38(5):357-62 - PubMed

Publication Types